G01N 2333/70571
For neuromediators
Official title: for neuromediators, e.g. serotonin receptor, dopamine receptor
G01N2333/70571 (For neuromediators) appears on 159 US grants and 225 published applications in this corpus.
Search patents in G01N- Granted patents
- 159
- Published applications
- 225
- Assignees
- 145
- Inventors
- 477
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 6 | 0 |
| 1999 | 8 | 0 |
| 2000 | 2 | 0 |
| 2001 | 5 | 1 |
| 2002 | 17 | 18 |
| 2003 | 9 | 13 |
| 2004 | 6 | 7 |
| 2005 | 6 | 11 |
| 2006 | 8 | 18 |
| 2007 | 2 | 6 |
| 2008 | 8 | 12 |
| 2009 | 6 | 8 |
| 2010 | 8 | 10 |
| 2011 | 5 | 9 |
| 2012 | 2 | 11 |
| 2013 | 11 | 10 |
| 2014 | 5 | 9 |
| 2015 | 4 | 10 |
| 2016 | 6 | 10 |
| 2017 | 3 | 6 |
| 2018 | 3 | 8 |
| 2019 | 5 | 5 |
| 2020 | 4 | 7 |
| 2021 | 3 | 6 |
| 2022 | 5 | 3 |
| 2023 | 1 | 4 |
| 2024 | 3 | 5 |
| 2025 | 2 | 11 |
| 2026 | 3 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-human neurotensin receptor 1 antibody and use thereof18 Aug 2026US 12,710,427 B2National Health Research Institutes
- Method of inhibiting tau phosphorylation7 Jul 2026US 12,674,134 B2Filana Therapeutics, Inc.
- Method of inhibiting tau phosphorylation23 Jun 2026US 12,662,658 B2Filana Therapeutics, Inc.
- Anti-NMDA receptor antibodies and methods of use11 Feb 2025US 12,221,484 B2Lankenau Institute for Medical Research
- Methods of treating epilepsy7 Jan 2025US 12,186,307 B2Yale University
- Methods of detecting and quantifying autoantibodies against neuronal antigens17 Sep 2026US 2026/0276635 A1Uni Pharma Co., Ltd.
- Antibodies for treating neurological and neurovascular disorders6 Aug 2026US 2026/0226177 A1
- Generation of antibodies acting as silent and positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor25 Jun 2026US 2026/0176364 A1
- Tests and methods for rapid and quantitative detection of an acetylcholine receptor ligand25 Jun 2026US 2026/0177568 A1
- Otic progenitor cell surface markers18 Jun 2026US 2026/0167930 A1WDI 2 ApS
Most cited
By later US patents
- Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions198US 7,048,906 B2Cedars-Sinai Medical Center · 2006
- Microscale assays and microfluidic devices for transporter, gradient induced, and binding activities179US 6,649,358 B1Caliper Technologies Corp. · 2003
- Certain alkylene diamine-substituted heterocycles126US 6,506,762 B1Neurogen Corporation · 2003
- Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia84US 7,081,239 B2Cedars-Sinai Medical Center Burns and Allen Research Center · 2006
- Identification of ligands by selective amplification of cells transfected with receptors82US 5,707,798 ANovo Nordisk A/S · 1998